Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current Strategies to Enhance Delivery of Drugs across the Blood–Brain Barrier
Raluca Ioana Teleanu, Manuela Daniela Preda, Adelina-Gabriela Niculescu, et al.
Pharmaceutics (2022) Vol. 14, Iss. 5, pp. 987-987
Open Access | Times Cited: 99

Showing 1-25 of 99 citing articles:

Alzheimer’s Disease: Treatment Strategies and Their Limitations
Elodie Passeri, Kamil Elkhoury, Margaretha Morsink, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13954-13954
Open Access | Times Cited: 213
Exosome Content–Mediated Signaling Pathways in Multiple Sclerosis
Mina Mohammadinasr, Soheila Montazersaheb, Hormoz Ayromlou, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 8, pp. 5404-5417
Closed Access | Times Cited: 12
Global Advancements in Bioactive Material Manufacturing for Drug Delivery: A Comprehensive Study
Rafael Leandro Fernandes Melo, Dayana Nascimento Dari, Francisco Izaias da Silva Aires, et al.
ACS Omega (2025) Vol. 10, Iss. 1, pp. 1207-1225
Open Access | Times Cited: 1
An Updated Overview of Cyclodextrin-Based Drug Delivery Systems for Cancer Therapy
Dan Nicolae Păduraru, Adelina-Gabriela Niculescu, Alexandra Bolocan, et al.
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1748-1748
Open Access | Times Cited: 38
Biosensor integrated brain-on-a-chip platforms: Progress and prospects in clinical translation
Berivan Çeçen, Ecem Saygılı, Iman Zare, et al.
Biosensors and Bioelectronics (2023) Vol. 225, pp. 115100-115100
Open Access | Times Cited: 20
An update on pathogenesis and clinical scenario for Parkinson’s disease: diagnosis and treatment
Hussaini Adam, Subash C. B. Gopinath, M. K. Md Arshad, et al.
3 Biotech (2023) Vol. 13, Iss. 5
Open Access | Times Cited: 20
Niosomal Bupropion: Exploring Therapeutic Frontiers through Behavioral Profiling
Karthick Harini, Suliman Yousef Alomar, Vajagathali Mohammed, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 3, pp. 366-366
Open Access | Times Cited: 11
Insights into Targeted and Stimulus‐Responsive Nanocarriers for Brain Cancer Treatment
Zahra Abousalman‐Rezvani, Ahmed Refaat, Pouya Dehghankelishadi, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 12
Open Access | Times Cited: 10
How Precise are Nanomedicines in Overcoming the Blood–Brain Barrier? A Comprehensive Review of the Literature
Priyadarshini Mohapatra, Mohanraj Gopikrishnan, C. George Priya Doss, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 2441-2467
Open Access | Times Cited: 9
Alzheimer’s disease and drug delivery across the blood–brain barrier: approaches and challenges
Iram Iqbal, Fatima Saqib, Zobia Mubarak, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 7
Unraveling the Complexity of Human Brain: Structure, Function in Healthy and Disease States
Omme Fatema Sultana, Madhuri Bandaru, Md. Ariful Islam, et al.
Ageing Research Reviews (2024) Vol. 100, pp. 102414-102414
Closed Access | Times Cited: 6
Revolutionizing Parkinson’s treatment: Harnessing the potential of intranasal nanoemulsions for targeted therapy
Gulshan Sharma, Karan Wadhwa, Shobhit Kumar, et al.
Drug Delivery and Translational Research (2025)
Closed Access
Evolution of Alzheimer’s Disease Therapeutics: From Conventional Drugs to Medicinal Plants, Immunotherapy, Microbiotherapy and Nanotherapy
Emma Ortiz, Pedro Montes, Citlali Ekaterina Rodríguez-Pérez, et al.
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 128-128
Open Access
Targeted drug delivery in neurodegenerative diseases: the role of nanotechnology
Rupal Dhariwal, Mukul Jain, Y. Mir, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Nanoengineered immune check point inhibitors delivery for targeted brain cancer treatment: Current status and future perspectives
Juan Liu, Yichao Wang, Zhidu Song, et al.
Biochemical Pharmacology (2025), pp. 116789-116789
Closed Access
Advancing CNS Therapeutics: Enhancing Neurological Disorders with Nanoparticle-Based Gene and Enzyme Replacement Therapies
Shuhan Liu, Haisong Li, Shiwen Xi, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 1443-1490
Open Access
Nanotechnology-based drug delivery for the treatment of CNS disorders
Khushi Mittal, Nandini Pharasi, Bhavya Sarna, et al.
Translational Neuroscience (2022) Vol. 13, Iss. 1, pp. 527-546
Open Access | Times Cited: 33
A Pralidoxime Nanocomplex Formulation Targeting Transferrin Receptors for Reactivation of Brain Acetylcholinesterase After Exposure of Mice to an Anticholinesterase Organophosphate
Kathleen F. Pirollo, Manish Moghe, Miaoyin Guan, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 307-326
Open Access | Times Cited: 5
Exosomes encapsulated in hydrogels for effective central nervous system drug delivery
Ziba Zakeri, Morteza Heiderzadeh, Azra Kocaarslan, et al.
Biomaterials Science (2024) Vol. 12, Iss. 10, pp. 2561-2578
Closed Access | Times Cited: 5
Advancements in neurotherapeutics: nanoparticles overcoming the blood–brain barrier for precise CNS targeting
Alaa Alqudah, Alaa A. A. Aljabali, Omar Gammoh, et al.
Journal of Nanoparticle Research (2024) Vol. 26, Iss. 6
Closed Access | Times Cited: 5
Anti-miRNA103/107 encapsulated in transferrin-conjugated lipid nanoparticles crosses blood-brain barrier and reduces brain ischemic damage
Pasquale Cepparulo, Ornella Cuomo, Virginia Campani, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 1, pp. 102131-102131
Open Access | Times Cited: 4
A blood–brain barrier- and blood–brain tumor barrier-penetrating siRNA delivery system targeting gliomas for brain tumor immunotherapy
Lin Tang, Rui Zhang, Yusi Wang, et al.
Journal of Controlled Release (2024) Vol. 369, pp. 642-657
Closed Access | Times Cited: 4
Effects of Ultrasound for Bio‐Applications
Likai Yuan, Qianqian Li, Zhen Li
Advanced Sensor Research (2024) Vol. 3, Iss. 8
Open Access | Times Cited: 4
Global Trends of Exosomes Application in Clinical Trials: A Scoping Review
Maryam Rahnama, Mohammad Heidari, Zahra Poursalehi, et al.
Stem Cell Reviews and Reports (2024) Vol. 20, Iss. 8, pp. 2165-2193
Closed Access | Times Cited: 4
Strategic nanocarriers to control neurodegenerative disorders: Concept, challenges, and future perspective
Sumel Ashique, Obaid Afzal, Sabina Yasmin, et al.
International Journal of Pharmaceutics (2023) Vol. 633, pp. 122614-122614
Closed Access | Times Cited: 12
Page 1 - Next Page

Scroll to top